Subscribe To
BDX / Becton, Dickinson and Company (BDX) CEO Thomas Polen on Q2 2022 Results - Earnings Call Transcript
BDX News
By Seeking Alpha
October 30, 2023
Becton, Dickinson And HP Among 13 Companies Announcing Annual Dividend Increases In The First Half Of November
Visa and Exxon Mobil announced dividend increases in October, with Visa increasing its dividend by 15.6% and Exxon Mobil increasing its dividend by 4. more_horizontal
By Seeking Alpha
October 4, 2023
Becton, Dickinson Stock Is A Hold, Here's Why
Becton, Dickinson and Company is a global healthcare company specializing in medical supplies, devices, and diagnostic products. BDX saw solid growth more_horizontal
By Zacks Investment Research
September 19, 2023
Here's Why You Should Hold BD (BDX) Stock in Your Portfolio
BD's (BDX) slew of product launches raises optimism about the stock. more_horizontal
By Zacks Investment Research
September 8, 2023
BD's (BDX) Tie-Up to Explore Flow Cytometry for Clinical Outcomes
BD's (BDX) latest partnership is likely to accelerate the delivery of innovative personalized therapies to patients who need them the most. more_horizontal
By InvestorPlace
August 30, 2023
Beyond Pills: 3 Non-Pharma Healthcare Stocks for Healthy Gains
When you consider healthcare stocks, do you automatically think of pharmaceutical companies? Most people do. more_horizontal
By Zacks Investment Research
August 3, 2023
Becton Dickinson (BDX) Q3 Earnings: Taking a Look at Key Metrics Versus Estimates
Although the revenue and EPS for Becton Dickinson (BDX) give a sense of how its business performed in the quarter ended June 2023, it might be worth c more_horizontal
By Reuters
August 3, 2023
Becton Dickinson beats quarterly profit estimates on strong medical device sales
Becton Dickinson beat Wall Street estimates for third-quarter profit on Thursday, helped by strong demand for its drug delivery devices and surgical e more_horizontal
By Zacks Investment Research
July 28, 2023
BD (BDX) Gears Up for Q3 Earnings: What's in the Offing?
Continued strength in BD's (BDX) Life Sciences segment's base business is expected to have benefited Q3 sales. more_horizontal